Key Takeaways Positive clinical results and safety profile of NK cell engagers boost potential revenue and adoption, enhancing net margins and efficacy. Strategic partnerships and capitalization efforts aim to improve financial stability and investor confidence, supporting long-term operations and earnings growth.